What Happened?
South San Francisco, CA-based ArsenalBio Appointed John Schroer as Chief Financial Officer
About the Company
ArsenalBio is a privately held, programmable cell therapy company focused on the realization of solid tumor cell therapy by helping more patients fight cancer and saving lives. Its discovery engine comprises non-viral manufacturing based on its CellFoundry™ technology, integrated circuits incorporating its PrimeR™ logic gates and CAR enhancements from its CARchitecture™ library, enabling multiple pharmaceutical functions. With our programmable and computationally driven approach, we aim for enhanced and broader efficacy, increased patient safety, reduced provider costs and expanded market access.
About the Person
John Schroer is Chief Financial Officer at ArsenalBio. Previously, John held various senior HR leadership roles in the industry.
Info Source
News
Short Profile